NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES1.

Authors: Chen T; Department of Urology, The First Affliated Hospital of Chongqing Medical University, Chongqing, China.; Department of Urology, Chongqing Jiangjin District Central Hospital, Chongqing, China., Yang X; Department of Urology, Chongqing Jiangjin District Central Hospital, Chongqing, China., Su S; Department of Urology, The First Affliated Hospital of Chongqing Medical University, Chongqing, China., Wang D; Department of Urology, The First Affliated Hospital of Chongqing Medical University, Chongqing, China.

Source: Molecular carcinogenesis [Mol Carcinog] 2026 Jan; Vol. 65 (1), pp. 138-145. Date of Electronic Publication: 2025 Nov 02.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

MeSH Terms: Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/metabolism , Methyltransferases*/metabolism , Methyltransferases*/genetics , Proto-Oncogene Proteins c-yes*/genetics , Proto-Oncogene Proteins c-yes*/metabolism, 5-Methylcytosine/metabolism ; Humans ; Male ; Cell Proliferation ; Cell Movement ; Proto-Oncogene Mas ; Animals ; Mice ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor ; Mice, Nude ; Xenograft Model Antitumor Assays

The regulation of organic anion transporting polypeptide 1B1 by nonreceptor tyrosine kinase YES1.

Authors: Wang X; Guangdong Laboratory for Lingnan Modern Agriculture, College of Life Sciences, South China Agricultural University, Guangzhou, China., Li Z; Guangdong Laboratory for Lingnan Modern Agriculture, College of Life Sciences, South China Agricultural University, Guangzhou, China., Tang L; Guangdong Laboratory for Lingnan Modern Agriculture, College of Life Sciences, South China Agricultural University, Guangzhou, China., Hong M; Guangdong Laboratory for Lingnan Modern Agriculture, College of Life Sciences, South China Agricultural University, Guangzhou, China; Guangdong Provincial Key Laboratory for the Development Biology and Environmental Adaptation of Agricultural Organisms, South China Agricultural University, Guangzhou, China. Electronic address: mh2788@scau.edu.cn.

Source: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2025 Dec; Vol. 53 (12), pp. 100194. Date of Electronic Publication: 2025 Nov 01.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

MeSH Terms: Liver-Specific Organic Anion Transporter 1*/metabolism , Proto-Oncogene Proteins c-yes*/metabolism , Proto-Oncogene Proteins c-yes*/genetics, Phosphorylation/drug effects ; Caveolin 1/metabolism ; src-Family Kinases/metabolism ; src-Family Kinases/antagonists & inhibitors ; Indoles/pharmacology ; Humans ; Proto-Oncogene Mas ; HEK293 Cells ; Biological Transport

Targeting YES1 enhances the efficacy of chemotherapy, targeted therapy and onco-immunotherapy.

Authors: Zheng D; School of Pharmacy, North China University of Science and Technology, 21 Bohai Road, Caofeidian District, Tangshan, China., Wang Y; School of Pharmacy, North China University of Science and Technology, 21 Bohai Road, Caofeidian District, Tangshan, China., Li J; Teaching and Experiment Center, Liaoning University of Traditional Chinese Medicine, Shenyang, China., Zhang G; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA., Chu E; Department of Oncology and Cancer Therapeutics Program, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: edward.chu@einsteinmed.edu., Wei N; Department of Oncology and Cancer Therapeutics Program, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: ning.wei@einsteinmed.edu.

Source: Cellular signalling [Cell Signal] 2025 Dec; Vol. 136, pp. 112108. Date of Electronic Publication: 2025 Sep 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 8904683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3913 (Electronic) Linking ISSN: 08986568 NLM ISO Abbreviation: Cell Signal Subsets: MEDLINE

MeSH Terms: Neoplasms*/therapy , Neoplasms*/drug therapy , Neoplasms*/immunology , Immunotherapy*/methods , Proto-Oncogene Proteins c-yes*/antagonists & inhibitors , Proto-Oncogene Proteins c-yes*/metabolism , Antineoplastic Agents*/therapeutic use , Antineoplastic Agents*/pharmacology , Molecular Targeted Therapy*, Tumor Microenvironment/drug effects ; Drug Resistance, Neoplasm/drug effects ; Protein Kinase Inhibitors/therapeutic use ; Signal Transduction/drug effects ; Humans ; Animals

A Pan-Cancer Analysis of the Oncogenic Role of YES Proto-Oncogene 1 (YES1) in Human Tumors.

Authors: Dou R; Department of Anesthesiology, Huadong Hospital, Fudan University, Shanghai, China., Han L; Department of Anesthesiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Liu G; Department of Emergency Surgery, Huadong Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China., Zhu X; Department of General Practice, Community Health Service Center of Xinjing Town, Shanghai, China., Yang Z; Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China., Hu P; Department of Emergency Surgery, Huadong Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China., Su Y; Department of Emergency Surgery, Huadong Hospital, Fudan University, Shanghai, China.; Department of General Surgery, Huadong Hospital, Fudan University, Shanghai, China.

Source: The journal of gene medicine [J Gene Med] 2025 Nov; Vol. 27 (11), pp. e70046.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9815764 Publication Model: Print Cited Medium: Internet ISSN: 1521-2254 (Electronic) Linking ISSN: 1099498X NLM ISO Abbreviation: J Gene Med Subsets: MEDLINE

MeSH Terms: Neoplasms*/genetics , Neoplasms*/metabolism , Neoplasms*/pathology , Proto-Oncogene Proteins c-yes*/genetics , Proto-Oncogene Proteins c-yes*/metabolism, Computational Biology/methods ; Tumor Microenvironment/genetics ; Biomarkers, Tumor/genetics ; Humans ; Proto-Oncogene Mas ; Gene Expression Regulation, Neoplastic ; Signal Transduction ; Prognosis ; Gene Expression Profiling

Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors.

Authors: Cuellar-Vite L; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Donaubauer EM; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio., Weber-Bonk KL; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Bobbitt JR; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio., Ingles NN; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio., Brzozowski TL; Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio., Abdul-Karim FW; Anatomic Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Booth CN; Anatomic Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Keri RA; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.; Department of General Medical Sciences-Oncology, School of Medicine, Case Western Reserve University, Cleveland, Ohio.

Source: Molecular cancer research : MCR [Mol Cancer Res] 2025 May 02; Vol. 23 (5), pp. 391-404.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

MeSH Terms: Protein Kinase Inhibitors*/pharmacology , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/metabolism , Proto-Oncogene Proteins c-yes*/genetics , Proto-Oncogene Proteins c-yes*/metabolism , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, ErbB Receptors/genetics ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Gene Expression Regulation, Neoplastic/drug effects ; Cell Proliferation/drug effects ; Humans ; Animals ; Mice ; Female ; Cell Line, Tumor ; Xenograft Model Antitumor Assays ; Mutation

MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1.

Authors: Mahboobnia K; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia.; Centre for Medical Research, The University of Western Australia, Perth, WA 6009, Australia., Kabir TD; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia.; Centre for Medical Research, The University of Western Australia, Perth, WA 6009, Australia., Hou R; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia., Liu P; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia., Forrest A; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia., Beveridge DJ; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia.; Centre for Medical Research, The University of Western Australia, Perth, WA 6009, Australia., Richardson KL; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia.; Centre for Medical Research, The University of Western Australia, Perth, WA 6009, Australia., Stuart LM; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia.; Centre for Medical Research, The University of Western Australia, Perth, WA 6009, Australia., Yeoh GC; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia.; School of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia., Leedman PJ; Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun St, Nedlands, Perth, WA 6009, Australia.; Centre for Medical Research, The University of Western Australia, Perth, WA 6009, Australia.

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Apr 27; Vol. 26 (9). Date of Electronic Publication: 2025 Apr 27.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH Terms: MicroRNAs*/genetics , MicroRNAs*/metabolism , Carcinoma, Hepatocellular*/genetics , Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/metabolism , Liver Neoplasms*/genetics , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/metabolism , Drug Resistance, Neoplasm*/genetics , Proto-Oncogene Proteins c-yes*/genetics , Proto-Oncogene Proteins c-yes*/metabolism, Gene Expression Regulation, Neoplastic/drug effects ; Cell Proliferation/drug effects ; Cell Proliferation/genetics ; Sorafenib/pharmacology ; Phenylurea Compounds/pharmacology ; Apoptosis/drug effects ; Apoptosis/genetics ; Quinolines/pharmacology ; Epithelial-Mesenchymal Transition/drug effects ; Epithelial-Mesenchymal Transition/genetics ; Cell Movement/drug effects ; Cell Movement/genetics ; Protein Kinase Inhibitors/pharmacology ; Signal Transduction/drug effects ; Humans ; Cell Line, Tumor

Targeting YES1 Disrupts Mitotic Fidelity and Potentiates the Response to Taxanes in Triple-Negative Breast Cancer.

Authors: Piemonte KM; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio.; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Ingles NN; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio., Weber-Bonk KL; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Valentine MJ; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Majmudar PR; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio.; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Singh S; Center for Immunotherapy and Precision Immuno-oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Keri RA; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Center for Immunotherapy and Precision Immuno-oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.; Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Source: Cancer research [Cancer Res] 2024 Nov 04; Vol. 84 (21), pp. 3556-3573.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

MeSH Terms: Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/metabolism , Mitosis*/drug effects , Forkhead Box Protein M1*/metabolism , Forkhead Box Protein M1*/genetics , Taxoids*/pharmacology , Proto-Oncogene Proteins c-yes*/genetics , Proto-Oncogene Proteins c-yes*/metabolism , Xenograft Model Antitumor Assays*, Centrosome/drug effects ; Centrosome/metabolism ; Gene Expression Regulation, Neoplastic/drug effects ; Chromosomal Instability/drug effects ; Humans ; Female ; Mice ; Animals ; Cell Line, Tumor

The tyrosine kinase Yes1 is a druggable host factor of HEV.

Authors: Haase JA; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany., Baheerathan A; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany., Zhang X; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Fu RM; Schaller Research Group, Department of Infectious Diseases and Virology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Biosciences International Graduate School, Heidelberg University, Heidelberg, Germany., Nocke MK; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany., Decker C; Schaller Research Group, Department of Infectious Diseases and Virology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Biosciences International Graduate School, Heidelberg University, Heidelberg, Germany., Dao Thi VL; Schaller Research Group, Department of Infectious Diseases and Virology, Heidelberg University Hospital, Heidelberg, Germany.; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany., Todt D; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany.; European Virus Bioinformatics Centre (EVBC), Jena, Germany., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Kaptein SJF; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium., Steinmann E; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany.; German Centre for Infection Research (DZIF), External Partner Site, Bochum, Germany., Kinast V; Department of Molecular and Medical Virology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany.; Department of Medical Microbiology and Virology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.

Source: Hepatology communications [Hepatol Commun] 2024 Oct 17; Vol. 8 (11). Date of Electronic Publication: 2024 Oct 17 (Print Publication: 2024).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: MEDLINE

MeSH Terms: Hepatocytes*/virology , Hepatocytes*/metabolism , Hepatitis E virus*/physiology , Hepatitis E virus*/genetics , Hepatitis E virus*/drug effects , Hepatitis E*/drug therapy , Hepatitis E*/virology , Proto-Oncogene Proteins c-yes*/genetics , Proto-Oncogene Proteins c-yes*/metabolism, Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Humans ; Animals ; Rats ; Rats, Nude ; Disease Models, Animal

ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis.

Authors: Tan S; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110000, China., Sun X; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110000, China., Dong H; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110000, China., Wang M; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110000, China., Yao L; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110000, China., Wang M; Department of Thyroid and Breast Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China., Xu L; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110000, China., Xu Y; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110000, China.

Source: Cancer biology & medicine [Cancer Biol Med] 2024 Jul 01; Vol. 21 (7).

Publication Type: Journal Article

Journal Info: Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN: 2095-3941 (Print) Linking ISSN: 20953941 NLM ISO Abbreviation: Cancer Biol Med Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Breast Neoplasms*/genetics , Coenzyme A Ligases*/metabolism , Coenzyme A Ligases*/genetics , YAP-Signaling Proteins*/metabolism , Transcription Factors*/metabolism , Transcription Factors*/genetics , Proto-Oncogene Proteins c-yes*/metabolism , Proto-Oncogene Proteins c-yes*/genetics , Lipid Metabolism* , Disease Progression* , Cell Proliferation* , Proto-Oncogene Mas*, Adaptor Proteins, Signal Transducing/metabolism ; Adaptor Proteins, Signal Transducing/genetics ; Humans ; Female ; Animals ; Mice ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Epithelial-Mesenchymal Transition ; Mice, Nude ; Prognosis ; Cell Movement ; Signal Transduction ; Metabolic Reprogramming ; Long-Chain-Fatty-Acid-CoA Ligase

SMFG Said to Weigh Strategy for India Assets Including Yes Bank.

Authors: Kalesh, Baiju (AUTHOR), Suzuki, Hideki (AUTHOR)

Source: Bloomberg.com. 7/10/2026, pN.PAG-N.PAG. 1p.

Subject Terms: *Financial services industry, *Equity stake, *Banking industry, *Regulatory approval, *Subsidiary corporations

Geographic Terms: India

Company/Entity: Sumitomo Mitsui Financial Group Inc. , YES Bank Ltd. , Sumitomo Mitsui Banking Corp.

SMBC-Backed Yes Bank Sees Indians Tip-Toeing Back to Deposits.

Authors: Nayak, Siddhi (AUTHOR)

Source: Bloomberg.com. 6/11/2026, pN.PAG-N.PAG. 1p.

Subject Terms: *Bank deposits, *Banking industry, *Stock funds, *Economic trends, *Loans, *Retail banking

Company/Entity: YES Bank Ltd.

Yes Bank Hikes FX Deposit Rates to Attract Non-Resident Inflows.

Authors: Nayak, Siddhi (AUTHOR)

Source: Bloomberg.com. 6/10/2026, pN.PAG-N.PAG. 1p.

Subject Terms: *Bank deposits, *Foreign exchange rates, *Capital movements, *Banking laws, *Banking industry, *Interest rates

Company/Entity: YES Bank Ltd.

Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells.

Authors: Cabral LK; Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park, Campus Basovizza, 34149 Trieste, Italy.; Philippine Council for Health Research and Development, Department of Science and Technology, Saliksik Building, Science Community Complex General Santos Ave., Bicutan, Taguig City 1631, Philippines., Disoma C; Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park, Campus Basovizza, 34149 Trieste, Italy.; Doctoral School of Molecular Biomedicine, Department of Life Sciences, University of Trieste, 34149 Trieste, Italy., Tarchi P; General Surgery Department, Azienda Sanitaria Universitaria Giuliano Isontina, 34128 Trieste, Italy., El-Khobar KE; Eijkman Research Center for Molecular Biology, Research Organization for Health, National Research and Innovation Agency of Indonesia (BRIN), Jakarta Pusat 10340, Indonesia., Agustiningsih A; Eijkman Research Center for Molecular Biology, Research Organization for Health, National Research and Innovation Agency of Indonesia (BRIN), Jakarta Pusat 10340, Indonesia., Dituri F; Personalized Medicine Laboratory, National Institute of Gastroenterology 'S. De Bellis' IRCCS Research Hospital, Via Turi 27, 70013 Bari, Italy., Tiribelli C; Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park, Campus Basovizza, 34149 Trieste, Italy., Sukowati C; Liver Cancer Unit, Fondazione Italiana Fegato ONLUS, AREA Science Park, Campus Basovizza, 34149 Trieste, Italy.; Eijkman Research Center for Molecular Biology, Research Organization for Health, National Research and Innovation Agency of Indonesia (BRIN), Jakarta Pusat 10340, Indonesia.

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jul 06; Vol. 26 (13). Date of Electronic Publication: 2025 Jul 06.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH Terms: Sorafenib*/pharmacology , Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/metabolism , Carcinoma, Hepatocellular*/genetics , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/metabolism , Liver Neoplasms*/genetics , src-Family Kinases*/antagonists & inhibitors , src-Family Kinases*/metabolism , src-Family Kinases*/genetics , Protein Kinase Inhibitors*/pharmacology , Antineoplastic Agents*/pharmacology, Cell Movement/drug effects ; Dasatinib/pharmacology ; Benzodioxoles/pharmacology ; Gene Expression Regulation, Neoplastic/drug effects ; Cell Proliferation/drug effects ; Proto-Oncogene Proteins c-yes/metabolism ; Proto-Oncogene Proteins c-yes/genetics ; Quinolones/pharmacology ; Cell Survival/drug effects ; Humans ; Cell Line, Tumor ; Quinazolines

Balancing Binary Biomedical QA: Parameter-Efficient Instruction Tuning on BioASQ and PubMedQA

Authors: Sarker, Tamal Kumar, Islam, Khandakar Jahidul, Sarker, Utpaul

Source: 2026 5th International Conference on Electrical, Computer & Telecommunication Engineering (ICECTE) Electrical, Computer & Telecommunication Engineering (ICECTE), 2026 5th International Conference on. :1-5 Jan, 2026

Relation: 2026 5th International Conference on Electrical, Computer & Telecommunication Engineering (ICECTE)

Biodegradable Nickel Phosphide Mediated Adenosine Metabolism and Hippo Pathway Inhibition for Synergistic Photothermal Immunotherapy

Authors: Yang, Yunan^aff1, Niu, Huina^aff1, Yu, Hang^aff1, Wang, Yuhang^aff2, Liu, Xin^aff1, Ren, Yiping^aff1, Wei, Liqi^aff1, Zou, Tianshu^aff1, Zhang, Qin^aff1, Ma, Hongxia^aff1, Cheng, Yan^aff1, Chen, Rui^aff2

Source: ACS Applied Materials & Interfaces. 18(16):22852-22862

Availability: https://pubs.acs.org/doi/10.1021/acsami.6c01262

Prevalence, multiterritorial vascular distribution, and burden of subclinical atherosclerosis in psoriasis: The EDSAP study

Authors: Abbad-Jaime de Aragon, Carlota, Berna-Rico, Emilio, Lecumberri, Alba, Perez-Bootello, Javier, Davó-Mogica, María, Neria-Serrano, Fernando, Monge, Diana, Ballester-Martínez, María Asunción, Pindado-Ortega, Cristina, Castellanos-González, María, Llamas-Velasco, Mar, Wasniewski, Samantha, Barderas, María G., Jaén, Pedro, Gelfand, Joel M., Mehta, Nehal N., Solís, Jorge, Fernández-Friera, Leticia, González-Cantero, Álvaro

Contributors: Facultad de Medicina, Universidad Francisco de Vitoria

Source: JAAD Int

Subject Terms: Inflammation, Epidemiology, psoriasis, Dermatology, Atherosclerosis, Cardiovascular disease, SDG 3 - Good Health and Well-being, cardiovascular disease, inflammation, Psoriasis, epidemiology, Original Article, atherosclerosis, Yes, yes

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/41630863
https://pubmed.ncbi.nlm.nih.gov/41630863/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12860958/
https://doi.org/10.1016/j.jdin.2025.11.026
https://hdl.handle.net/10641/7856

Fishery products consumption: Evidence of persistence and trends in 25 OECD countries

Authors: Solarin, Sakiru Adebola, Lafuente, Carmen, Gil-Alana, Luis Alberiko, González-Blanch, María Jesús

Contributors: Facultad de Derecho, Empresa y Gobierno

Source: Aquaculture and Fisheries. 11:375-383

Subject Terms: Fractional integration, Ecology, Fishery products consumption, OECD countries, Aquatic Science, Yes, yes, Fisheries management policy, Ecology, Evolution, Behavior and Systematics

File Description: application/pdf

Access URL: https://hdl.handle.net/10641/7562

YES Bank Limited.

Source: Ace Analyser: Conference Calls. 4/18/2026, p1-16. 17p.

Subject Terms: *Financial statements, *Nonperforming loans, *Financial institutions, *Corporate profits, *Interest income, *Earnings announcements, Geopolitics

Company/Entity: YES Bank Ltd.

Nanoengineered Light-Switchable Micelles for Dual Chemo-Photodynamic Immunotherapy in Esophageal Cancer via Spatiotemporal Control of the Tumor Microenvironment

Authors: Kang, Bingkun^{aff1, aff2}, Zeng, Lingjun^aff1, Xu, Shiting^{aff1, aff2}, You, Kaiqin^{aff1, aff2}, Lin, Shuang^{aff1, aff3}, Xiao, Longyun^{aff1, aff3}, Zheng, Da^{aff1, aff3}, Gao, Wenhao^{aff1, aff2}, Zhou, Xin^aff1

Source: ACS Applied Materials & Interfaces. 17(52):70550-70568

Availability: https://pubs.acs.org/doi/10.1021/acsami.5c20215

Impaired Sphingosine-1-Phosphate Synthesis Induces Preeclampsia by Deactivating Trophoblastic YAP (Yes-Associated Protein) Through S1PR2 (Sphingosine-1-Phosphate Receptor-2)-Induced Actin Polymerizations.

Authors: Liao J; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Zheng Y; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; Department of Stem Cell Transplantation and Cell Therapy, MD Anderson Cancer Center, Houston, TX (Y.Z.)., Hu M; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Xu P; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Lin L; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Liu X; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Wu Y; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Huang B; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Ye X; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Li S; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Duan R; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Fu H; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Huang J; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Wen L; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Fu Y; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.)., Kilby MD; Institute of Metabolism and System Research, College of Medical & Dental Sciences, University of Birmingham and the Fetal Medicine Centre, Birmingham Women's and Children's Foundation Trust, United Kingdom (M.D.K.)., Kenny LC; Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, United Kingdom (L.C.K.)., Baker PN; College of Life Sciences, University of Leicester, United Kingdom (P.N.B.)., Qi H; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; Chongqing Women and Children's Health Center, China (H.Q.)., Tong C; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, The First Affiliated Hospital of Chongqing Medical University, China (J.L., Y.Z., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).; State Key Laboratory of Maternal and Fetal Medicine of Chongqing Municipality, China (J.L., M.H., P.X., L.L., X.L., Y.W., B.H., X.Y., S.L., R.D., H.F., J.H., L.W., Y.F., H.Q., C.T.).

Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2022 Feb; Vol. 79 (2), pp. 399-412. Date of Electronic Publication: 2021 Dec 06.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4563 (Electronic) Linking ISSN: 0194911X NLM ISO Abbreviation: Hypertension Subsets: MEDLINE

MeSH Terms: Actins/*metabolism , Lysophospholipids/*metabolism , Pre-Eclampsia/*metabolism , Proto-Oncogene Proteins c-yes/*metabolism , Sphingosine/*analogs & derivatives , Sphingosine-1-Phosphate Receptors/*metabolism , Trophoblasts/*metabolism, Lysophospholipids/genetics ; Placenta/metabolism ; Placentation/physiology ; Proto-Oncogene Proteins c-yes/genetics ; Signal Transduction/physiology ; Sphingosine/genetics ; Sphingosine/metabolism ; Sphingosine-1-Phosphate Receptors/genetics ; Animals ; Female ; Humans ; Mice ; Pregnancy